Assyro AI

FDA Orange Book · active-ingredient family

Phenobarbital sodium

Phenobarbital sodium is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:SEZABY · NDA 215910

1

Brand (NDA)

0

Generics (ANDA)

2

Listed patents

1

Exclusivity periods

Brand (NDA) products · powder

ProductApplicantApplicationTEApproved
SEZABYRLDSUN PHARM INDS INCNDA 215910Nov 17, 2022

Marketing exclusivity (1)

  • ODE-414Orphan-drug exclusivity (7 years)

    Nov 17, 2029

    in 3 yr 6 mo

Listed patents (2)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
11857683Apr 07, 2042in 16 yr
ProductU-3779
12636254Apr 07, 2042in 16 yr
ProductU-3779

Phenobarbital sodium — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.